Answers are grounded in this paper and cite their sources.
Few would argue that regulatory decisions related to chemical substances, whether pre-market authorisations, setting of health-based reference values and environmental quality standards, or prioritizing for future testing and management measures, ought to be based on less than all reliable and relevant evidence
No takes yet. Share an insight, caveat, or question.
Martin et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: